Successful desensitization to gonadotropin-releasing hormone analogue triptorelin acetate using a sustained-release depot preparation

by Chan Ng P., Huang C.-H., Rajakulendran M., Tan M.M., Wang P.P., Tay L.Q., Goh S.Y., Shek L.P.-C., Tham E.H.
Published 2020

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

by Wee, Z.N, Yatim, S.M.J.M, Kohlbauer, V.K, Feng, M, Goh, J.Y, Yi, B, Lee, P.L, Zhang, S, Wang, P.P, Lim, E, Tam, W.L, Cai, Y, Ditzel, H.J, Hoon, D.S.B, Tan, E.Y, Yu, Q
Published 2020

Erratum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (Nature Communications (2015) 6 (8746) DOI: 10.1038/ncomms9746)

by Wee, Z.N., Yatim, S.M.J.M., Kohlabauer, V.K., Feng, M., Goh, J.Y., Bao, Y., Lee, P.L., Zhang, S., Wang, P.P., Lim, E., Tam, W.L., Cai, Y., Ditzel, H.J., Hoon, D.S.B., Tan, E.Y., Yu, Q.
Published 2020